Advertisements


We are Sorry, This Page doesn't Exist


Gilead Works To "Maximize Global Supply" Of Coronavirus Candidate Remdesivir Amid Threat Of Patent Loss

Gilead Sciences, Inc. (NASDAQ: GILD) recently received emergency use authorization from the FDA for its coronavirus treatment candidate remdesivir. read more.....»»

Category: blogSource: benzingaMay 6th, 2020

Trump: Gilead gets emergency FDA authorization for remdesivir

The Food and Drug Administration has granted emergency use authorization for Gilead's remdesivir drug to treat the coronavirus, President Donald Trump announced Friday......»»

Category: topSource: moneycentralMay 1st, 2020

Trump: Gilead gets emergency FDA authorization for remdesivir

The Food and Drug Administration has granted emergency use authorization for Gilead's remdesivir drug to treat the coronavirus, President Donald Trump announced Friday......»»

Category: topSource: moneycentralMay 1st, 2020

FDA grants Gilead’s remdesivir emergency authorization for COVID-19 treatment

The Food and Drug Administration on Friday granted an emergency use authorization to Gilead Sciences Inc.’s remdesivir, a decade-old experimental therapy first tested on Ebola disease patients, as a COVID-19 treatment......»»

Category: topSource: marketwatchMay 1st, 2020

FDA clears Gilead"s emergency coronavirus treatment remdesivir

The Food and Drug Administration has authorized the emergency use of Gilead’s experimental drug remdesivir for COVID-19 treatment......»»

Category: topSource: foxnewsMay 1st, 2020

Trump says Gilead gets emergency FDA authorization for remdesivir to treat coronavirus: reports

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 1st, 2020

Anti-malarial drug Trump touted is linked to higher rates of death in VA coronavirus patients, study says

Rates of death in the groups treated with the drugs were worse than for those who received no treatment, and rates of patients on ventilators were similar, the study found......»»

Category: topSource: washpostApr 22nd, 2020

Johnson & Johnson: Coronavirus vaccine testing to begin by Sept.

Johnson & Johnson said on Monday human testing of its experimental vaccine for the coronavirus would begin by September and that it could be available for emergency use authorization in early 2021......»»

Category: topSource: moneycentralMar 30th, 2020

Johnson & Johnson says testing of coronavirus vaccine to begin by September

Johnson & Johnson said on Monday human testing of its experimental vaccine for the coronavirus would begin by September and that it could be available for emergency use authorization in early 2021......»»

Category: topSource: moneycentralMar 30th, 2020

Johnson & Johnson says testing of coronavirus vaccine to begin by September

Johnson & Johnson said on Monday human testing of its experimental vaccine for the coronavirus would begin by September and that it could be available for emergency use authorization in early 2021......»»

Category: topSource: reutersMar 30th, 2020

Abbott Labs releases coronavirus test system that has results in 5 minutes

Abbott Laboratories said it has received emergency-use authorization from the U.S. Food and Drug Administration for its device that can render positive results for the coronavirus in five minutes. The Abbott Park, Illinois-based pharmaceutical compa.....»»

Category: topSource: bizjournalsMar 28th, 2020

PerkinElmer gets emergency OK from FDA for coronavirus test

PerkinElmer Inc. said late Tuesday it received an emergency use authorization from the Food and Drug Administration so labs can start using its test for SARS-CoV-2.....»»

Category: topSource: marketwatchMar 24th, 2020

Abbott Labs gets FDA green light to ship coronavirus tests

Abbott Laboratories said late Wednesday that it received an emergency authorization from the Food and Drug Administration to ship 150,000 tests for COVID-19, or infection from the SARS-CoV-2 coronavirus. The tests .....»»

Category: topSource: marketwatchMar 18th, 2020

Novavax"s stock jumps after Biden mentions its COVID-19 vaccine candidate

Shares of Novavax Inc. gained 12.1% in trading on Tuesday after President Joe Biden mentioned that the company's experimental COVID-19 vaccine may be nearing emergency-use authorization in the U.S. "The problem is right now we have to make sure w.....»»

Category: topSource: marketwatchApr 27th, 2021

Eli Lilly asks FDA to revoke EUA for COVID antibody treatment alone to speed transition to combination therapy

Eli Lilly and Co. said Friday it is seeking a revocation of the emergency use authorization granted by U.S. regulators for its bamlanivimab antibody treatment for COVID-19 alone in order to complete the transition to bamlanivimab and etesevim.....»»

Category: topSource: marketwatchApr 16th, 2021

BD gets FDA authorization for test that can detect COVID-19 and the flu

Becton, Dickinson & Co. said it received emergency autho.....»»

Category: topSource: marketwatchMar 30th, 2021

GlaxoSmithKline and Vir Biotech seek FDA emergency authorization for COVID antibody treatment

GlaxoSmithKline PLC and Vir Biotechnology Inc. said Friday they have submitted to the U.S. Food and Drug Administration an application for emergency use authorization for their antibody treatment for mild-to-moderate COVID-19 in adults and adolesce.....»»

Category: topSource: marketwatchMar 26th, 2021

Canada authorizes J&J"s COVID-19 vaccine

Shares of Johnson & Johnson gained 1.4% in trading on Friday after Canada's health regulatory body said it authorized the company's COVID-19 vaccine. The single-dose vaccine received emergency use authorization in t.....»»

Category: topSource: marketwatchMar 5th, 2021

Trump privately received the coronavirus vaccine while he was president in January

Trump and former first lady Melania Trump got the COVID-19 v.....»»

Category: topSource: businessinsiderMar 1st, 2021

Johnson & Johnson"s Vaccine Gets Unanimous Backing Of FDA Panel, Emergency-Use Authorization Soon To Come

Johnson & Johnson's (NYSE: JNJ) coronavirus vaccine candidate could be given clearance for emergency use today, following unanimous backing by a Food and Drug Administration panel. read more.....»»

Category: blogSource: benzingaFeb 27th, 2021